Scientist search brain for origins of risk-taking

imgres

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

At Stanford University, a rat faces a choice. If it presses one lever, it gets a fixed amount of sugar liquid. If it presses a second lever, it usually gets less but occasionally wins a sweet bonanza. This choice between a safe bet and a risky gamble is one of life’s most recurring and most important. It affects whether an animal gets a meal or a teenager drunkenly climbs behind a wheel, whether an entrepreneur rakes in the cash or a global financial system collapses. And, if the Stanford rats are any indicator, it’s a choice whose outcome can be predicted and controlled.

By studying the brains of these rodents, Kelly Zalocusky from Stanford University has identified a specific group of neurons that are involved in risky decision-making. Their activity reveals whether a rat is about to make a safe choice or take a punt on a bigger payoff. And by silencing these neurons at the right time, Zalocusky’s team, led by Karl Deisseroth, could instantly (and temporarily) convert the risk-taking rodents into risk-avoiders.

If the same applies to humans, the study may have implications for treating addictive disorders. But perhaps more importantly, it reveals something about how we make decisions and where our attitudes toward risk come from. It’s not about what we gain from winning, but about how we deal with losing.

Read full, original post: Scientists Can Now Watch the Brain Evaluate Risk

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-Sep-10-2026-10_36_07-AM
Viewpoint: Even lousy scientific articles can shield authors when they hype dubious health claims and products
sorghum farmers in kenya FARMERS TREND
Here are all the ways CRISPR gene editing is transforming Africa’s staple crops—and there’s a lot more innovation to come
Screenshot-2026-10-01-at-11.21.27-AM
Vaccine hesitancy, like malaria, surges globally, topping 35% in some countries
ChatGPT-Image-Sep-30-2026-01_11_07-PM
How U.S. teamed with Russia to block global human AI weapons oversight
ChatGPT-Image-Sep-21-2026-03_15_09-PM
Viewpoint: Chipotle-inspired lesson: 10,000 sick customers suggest that processed foods can be safer than fresh ones
ChatGPT-Image-Sep-30-2026-01_25_34-PM
Blood tests for Alzheimer’s? The latest grifter, social media scam.
generated-1790707585414
Facts & Fallacies podcast: America's health care system is broken. A doctor explains how to fix it
ChatGPT-Image-Sep-30-2026-01_38_36-PM
Viewpoint: Died “with measles” vs. died “from measles”: RFK, Jr.’s dangerously subversive word games
ChatGPT-Image-Sep-29-2026-12_16_42-PM
Social media influencers are driving food misinformation across Europe
Screenshot-2026-09-28-at-1.16.38-PM
Defying public perceptions, U.S. cancer deaths plunged 35% since 1991
Screenshot-2026-09-17-at-1.07.08-PM
'We are dangerously addicted to antidepressants': Should we heed RFK Jr.’s sobering warning?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.